RxDoctor Payments Data

Reinald Revilla

Psychiatric/Mental Health · Torrance, CANPI 1821507716

Payments from drug & device makers

$2,299in general payments, 2019–2025

Across 94 payments — averaging $24.46 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$442
  • Otsuka America Pharmaceutical, Inc.$381
  • ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$338
  • Alkermes, Inc.$338
  • Johnson & Johnson$310
  • E.r. Squibb & Sons, L.L.C.$146
  • plus $344 from 8 others

What the payments were for

  • Food & beverage$2,299100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,299 in reported general payments places this provider in the 80th percentile of 2,433 psychiatric/mental health providers in California.

See all psychiatric/mental health providers in California

Medicare billing

Part B allowed, 2024
$14,213
Medicare patients
25
Services billed
123

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Lisdexamfetamine Dimesylate29$6,550
Lurasidone Hcl21$4,423
Dextroamphetamine Sulfate12$2,458
Duloxetine Hcl68$878
Amitriptyline Hcl11$763
Aripiprazole27$569
Guanfacine Hcl ErGuanfacine Hcl31$552
Sertraline Hcl104$496
Escitalopram Oxalate30$492
Bupropion XlBupropion Hcl50$491
Asenapine Maleate14$477
Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine13$397
Trazodone Hcl60$378
Eszopiclone18$304
Fluoxetine Hcl37$300

Paid to pharmacies, not to this prescriber.

Other psychiatric/mental health in Torrance

See the full list for California

Where these figures come from

Is this you, or does something look wrong? →